WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 12'5501 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 18'1941 Child (under 5 years) mortality rate: 152

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 30'405  29'955  29'501  29'043  28'583  24'408  19'741  15'096 
Births 601  601  601  601  600  576  565  499 
Surviving infants 592  592  592  591  590  565  551  481 
Pop. less than 5 years 2'955  2'951  2'944  2'934  2'925  2'782  2'726  2'295 
Pop. less than 15 years 8'678  8'641  8'602  8'560  8'523  8'232  7'505  6'140 
Female 15-49 years 8'014  7'917  7'815  7'706  7'593  6'377  4'948  3'634 

Number of reported case

(Click for retrospective incidence data for Venezuela (Bolivarian Republic of))
Diphtheria 31 
Japanese encephalitis
Measles 22  9'881  9'750 
Mumps 15  2'740  3'353  7'509  5'851 
Pertussis 555  1'389  3'247 
Polio* 11 
Rubella 13'927 
Rubella (CRS)
Tetanus (neonatal) 28  129 
Tetanus (total) 14  26  13  17  27  99  476 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Venezuela (Bolivarian Republic of))
Vaccine year result method % card seen                                                
BCG 1999  90  MICS     95  96  95  92  91  99  82  72 
DTP1 1999  88  MICS     90  90  90  90  86  92 
DTP3 1999  59  MICS     82  81  78  78  84  77  63  56 
HepB_BD          80  67  78  73  66  14 
HepB3          82  81  78  78  84 
Hib3          82  81  78  78  84 
JapEnc         
MCV 1999  57  MICS     85  87  86  79  87  84  62  50 
MCV2          38  33  26  31 
PCV1         
PCV3         
Pol3 1999  40  MICS     82  73  78  74  75  86  72  95 
Rota1          83  83  76  65  55 
Rota_last          77  76  66  49  54 
Rubella1          85  87  86  79  87 
TT2plus          48  51  37  32  26 
PAB         
VAD1         
YFV          85  87  73  48  77  17 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Venezuela (Bolivarian Republic of))
BCG 95  96  95  92  91  99  82  72 
DTP1 90  90  90  90  86  92  84  79 
DTP3 82  81  78  78  84  77  63  56 
HepB3 82  81  78  78  84 
HepB_BD 80  67  78  73  66  14 
Hib3 82  81  78  78  84 
MCV 85  87  86  79  87  84  61  50 
MCV2 38  33  26  31 
PAB 75  50  50  50  50 
PnC3
Pol3 82  73  78  74  75  86  72  95 
Rota_last 77  76  66  49  54 
YFV 85  87  73  48  77  17 

Number of districts in the country 335  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 33
From 80 to 89% 20
From 50 to 79% 42
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 2, 4, 6, 18 months; 5 years; Yes
HepB birth; Yes and 3 doses for adults
Influenza 6, 7 months; Yes and risk groups and ederly
MMR 12 months; 5 years; Yes
MenBC 1, 2 days; risk groups
OPV 2, 4, 6, 18 months; 5 years; Yes
Pneumo_conj 2, 4, 5 months; +1 year; Yes From July 2014
Pneumo_ps > 60 years; + 5 years; Yes
Rotavirus 2, 4 months; Yes
Td 1st contact; +1, +6 months; +1, +1 year; Yes
YF 1 year; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  No  No  No  NA  No 
What years does the MYP cover? number 2013-2018             
Nº of districts with microplans that include activities to raise immunization coverage number     250     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 335  335  367  367  367  367  367 
Nº districts with DTP3 coverage >=80% number 178  188  189  165  173  35 
% of districts with DTP3 coverage >=80% From 0 to 100% 53  56  51  45  47  10 
Nº districts with measles (MCV1) coverage >=95% number 91  103  113  76  91     
% of districts with MCV1 coverage >=95% From 0 to 100% 27  31  31  21  25     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  Yes  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes    Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100    100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.